Bull case
HLI would need investors to value it at roughly 39x earnings — about 20x more generous than today's 19x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where HLI stock could go
HLI would need investors to value it at roughly 39x earnings — about 20x more generous than today's 19x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 29x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 4x multiple contraction could push HLI down roughly 19% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Houlihan Lokey is a global investment bank specializing in middle-market mergers and acquisitions, financial restructuring, and valuation advisory services. It generates revenue primarily from advisory fees across three segments: Corporate Finance (~60% of revenue), Financial Restructuring (~25%), and Financial and Valuation Advisory (~15%). The firm's key competitive advantage is its dominant market position in middle-market M&A and restructuring—particularly its reputation for fairness opinions and creditor advisory work—which creates deep client relationships and repeat business.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q2 2025 | $1.96/$1.62 | +21.0% | $666M/$628M | +6.1% |
| Q3 2025 | $2.14/$1.68 | +27.4% | $605M/$580M | +4.4% |
| Q4 2025 | $1.84/$1.68 | +9.5% | $659M/$652M | +1.2% |
| Q1 2026 | $1.94/$1.85 | +4.9% | $717M/$697M | +2.9% |
HLI beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $137 — implies -10.2% from today's price.
| Metric | HLI | S&P 500 | Financial Services | 5Y Avg HLI |
|---|---|---|---|---|
| Forward PE | 19.1x | 19.1x | 10.5x+82% | — |
| Trailing PE | 25.3x | 25.2x | 13.4x+89% | 22.1x+14% |
| PEG Ratio | 1.61x | 1.75x | 1.03x+57% | — |
| EV/EBITDA | 17.9x | 15.3x+18% | 11.4x+57% | 14.4x+24% |
| Price/FCF | 12.7x | 21.3x-40% | 10.6x+19% | 26.5x-52% |
| Price/Sales | 4.3x | 3.1x+37% | 2.3x+91% | 3.6x+19% |
| Dividend Yield | 1.63% | 1.88% | 2.68% | 1.90% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolHLI generates 20.1% ROE and 11.9% return on assets — the two primary signals for banking profitability. FCF-based metrics are not applicable to financial companies.
Revenue, profitability, and return on capital
ROIC, leverage, and debt serviceability
Traditional FCF and debt/FCF ratios are not meaningful for financial companies. Focus on ROE and ROA above.
How capital is returned to owners
All figures from the trailing twelve months. For financial companies, ROE and ROA are the primary health signals — FCF-based metrics are not applicable.
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 29, 2026
Houlihan Lokey's revenue is closely tied to M&A and capital market activity. A recession or significant market downturn could lead to a sharp decline in deal volumes, directly impacting the company's revenue and profitability.
The success of Houlihan Lokey heavily relies on retaining its Managing Directors and senior professionals. The loss of key talent could adversely affect the business and its operational capabilities.
The company's revenue and profits can be highly volatile on a quarterly basis, leading to fluctuations in its stock price. This volatility can create uncertainty for investors regarding future performance.
Houlihan Lokey faces reputational and legal risks from potential employee misconduct, conflicts of interest, and cybersecurity breaches. Such issues could lead to significant financial and operational repercussions.
Analyses suggest that Houlihan Lokey's stock may be overvalued, trading at a premium to its intrinsic worth. This could indicate potential downside risk, especially if market conditions change.
The investment banking industry is highly competitive, with Houlihan Lokey facing pressure from other firms. Increased competition could impact market share and profitability.
The financial industry faces challenges such as increased regulation and compensation pressures, leading to talent dislocation. This environment can affect the availability and cost of skilled professionals.
While Houlihan Lokey's focus on the middle market is a strength, it can also result in less visibility into future performance. This may increase the risk profile of its financial stability.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 29, 2026
Houlihan Lokey has demonstrated significant revenue and earnings growth, with fiscal year 2025 revenue increasing by 24.80% year-over-year to $2.39 billion and earnings rising by 42.60% to $399.71 million. Analysts project continued growth, with EPS expected to grow at an average yearly rate of 16.34% and revenue by 13.02% in the coming years.
The company's business model combines corporate finance (cyclical) with financial restructuring (countercyclical), allowing it to perform well in various economic conditions. This diversification provides a 'natural hedge,' enabling HLI to generate revenue even when M&A activity slows down.
Houlihan Lokey is a leading M&A advisor in the United States, particularly in the middle-market segment (transactions under $1 billion), which accounts for a vast majority of global deal activity. This focus positions them to capture significant deal volume.
The company is investing in technology, including a centralized AI orchestration layer and the monetization of proprietary M&A data, which could drive future growth. Additionally, expansion into Europe through acquisitions strengthens its global presence.
Houlihan Lokey maintains a strong balance sheet with substantial cash reserves and minimal debt, providing financial flexibility. This financial strength supports its growth initiatives and positions the company well for future opportunities.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
HLI HLI Houlihan Lokey, Inc. | $10.3B | 19.1x | +22.6% | — | Buy | +35.8% |
EVR EVR Evercore Inc. | $13.2B | 17.6x | +27.8% | — | Buy | +14.8% |
PJT PJT PJT Partners Inc. | $3.7B | 20.4x | +13.9% | — | Hold | +4.3% |
LAZ LAZ Lazard Ltd | $4.4B | 14.6x | +3.8% | — | Buy | +1.7% |
MC MC Moelis & Company | $4.7B | 20.8x | +24.6% | — | Hold | +15.1% |
PWP PWP Perella Weinberg Partners | $2.0B | 17.5x | -9.2% | — | Buy | +4.7% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
HLI returns 2.2% total yield, led by a 1.63% dividend, raised 10 consecutive years. Buybacks add another 0.5%.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.60 | — | — | — |
| 2025 | $2.37 | +4.9% | 0.5% | 2.0% |
| 2024 | $2.26 | +3.7% | 0.3% | 2.0% |
| 2023 | $2.18 | +7.9% | 0.8% | 3.2% |
| 2022 | $2.02 | +24.7% | 5.1% | 7.0% |
Common questions answered from live analyst data and company financials.
Houlihan Lokey, Inc. (HLI) is rated Buy by Wall Street analysts as of 2026. Of 15 analysts covering the stock, 9 rate it Buy or Strong Buy, 5 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $200, implying +35.8% from the current price of $147. The bear case scenario is $119 and the bull case is $303.
The Wall Street consensus price target for HLI is $200 based on 15 analyst estimates. The high-end target is $211 (+43.3% from today), and the low-end target is $193 (+31.1%). The base case model target is $220.
HLI trades at 19.1x times forward earnings. The stock's valuation is broadly in line with the broader market. Based on current multiples versus the peer group, the relative model signals slightly overvalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for HLI in 2026 are: (1) Market Volatility — Houlihan Lokey's revenue is closely tied to M&A and capital market activity. (2) Dependence on Key Personnel — The success of Houlihan Lokey heavily relies on retaining its Managing Directors and senior professionals. (3) Revenue Volatility — The company's revenue and profits can be highly volatile on a quarterly basis, leading to fluctuations in its stock price. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates HLI will report consensus revenue of $2.9B (+22.6% year-over-year) and EPS of $7.21 (+10.1% year-over-year) for the upcoming fiscal year. The following year, analysts project $3.6B in revenue.
Houlihan Lokey, Inc. is expected to report its next earnings on approximately 2026-05-06. Consensus expects EPS of $1.79 and revenue of $679M. Over recent quarters, HLI has beaten EPS estimates 92% of the time.
Houlihan Lokey, Inc. (HLI) generated $739M in free cash flow over the trailing twelve months. HLI returns capital to shareholders through dividends (1.6% yield) and share repurchases ($53M TTM).